Pediatric Neurology
Volume 40, Issue 3 , Pages 189-196, March 2009

Outcomes for the Extremely Premature Infant: What Is New? and Where Are We Going?

  • Charlene M.T. Robertson, MD

      Affiliations

    • Section of Pediatric Neurosciences, Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada
    • Pediatric Rehabilitation, Outcomes Evaluation and Research, Glenrose Rehabilitation Hospital, Edmonton, Alberta, Canada
    • Department of Pediatrics, Glenrose Rehabilitation Hospital, Edmonton, Alberta, Canada
    • Corresponding Author InformationCommunications should be addressed to: Dr. Robertson; Pediatrics, Room 242, GlenEast; 10230 - 111 Avenue; Edmonton, AB T5G 0B7, Canada.
  • ,
  • Man-Joe Watt, MD

      Affiliations

    • Section of Pediatric Neurosciences, Department of Pediatrics, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada
    • Department of Pediatrics, Glenrose Rehabilitation Hospital, Edmonton, Alberta, Canada
    • Department of Rehabilitation Medicine, Glenrose Rehabilitation Hospital, Edmonton, Alberta, Canada
  • ,
  • Irina A. Dinu, PhD

      Affiliations

    • School of Public Health, University of Alberta, Edmonton, Alberta, Canada

Received 14 May 2008; accepted 7 August 2008.

Two approaches were taken to determine what is new and where we are going in terms of outcomes for the extremely premature infant: publications from 2004 to 2007 were reviewed, and the 30-year outcome at the authors' institutions was assessed. Recent literature documents improving early childhood outcomes in the face of improved survival. Childhood cerebral palsy prevalence rates have been reported to be as low as 19 per 1000 live births for infants born at 20-27 weeks gestation. Vision and hearing loss have been reported in fewer than 1% of survivors. The rate of overall intellectual impairment has not improved, although impairment was reduced in a recent trial of caffeine therapy for apnea of prematurity, and this remains an important area for study. In sum, recent findings herald a more positive perspective on the outcome for extremely premature survivors. It can thus be expected that new intensive-care trials will attempt to reduce the proportion of survivors with adverse outcomes. Childhood assessments will have a greater focus on function and participation. Information on improved outcomes for preterm infants will inform guidelines of decision making used to help parents to determine what is best for their child. The audit component of follow-up studies will expand and more cohort and trial studies will become multicenter, national, and international.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0887-8994(08)00478-5

doi:10.1016/j.pediatrneurol.2008.09.017

Pediatric Neurology
Volume 40, Issue 3 , Pages 189-196, March 2009